Evidence map›Paper›PMID 41426519›Full record

ReviewNanoscale advances2026

Targeted nanocarriers integrating photodynamic and photothermal therapy: a paradigm shift in rheumatoid arthritis treatment.

Sakshi Priya, Dhruv Sharma, Kaushal K Jain, Sahiba Chutani, Gautam Singhvi

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Nanoscale advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sakshi PriyaIndustrial Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science, Pilani Pilani Campus, Vidya Vihar Pilani Rajasthan 333031 India gautam.singhvi@pilani.bits-pilani.ac.in.
Dhruv SharmaIndustrial Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science, Pilani Pilani Campus, Vidya Vihar Pilani Rajasthan 333031 India gautam.singhvi@pilani.bits-pilani.ac.in.
Kaushal K JainIndustrial Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science, Pilani Pilani Campus, Vidya Vihar Pilani Rajasthan 333031 India gautam.singhvi@pilani.bits-pilani.ac.in.
Sahiba ChutaniIndustrial Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science, Pilani Pilani Campus, Vidya Vihar Pilani Rajasthan 333031 India gautam.singhvi@pilani.bits-pilani.ac.in.
Gautam SinghviIndustrial Research Laboratory, Department of Pharmacy, Birla Institute of Technology and Science, Pilani Pilani Campus, Vidya Vihar Pilani Rajasthan 333031 India gautam.singhvi@pilani.bits-pilani.ac.in.ORCID https://orcid.org/0000-0002-9706-9244

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Rheumatoid Arthritis (RA) is a crippling autoimmune disease characterized by gradual cartilage loss, bone degeneration, and persistent joint inflammation. Widespread adverse effects and ineffective drug distribution hamper the traditional treatment modalities. Recent progress in RA treatment has been advanced by nanocarrier-based phototherapies, including photodynamic therapy (PDT) and photothermal therapy (PTT). These therapies work by inducing necrosis or apoptosis in inflammatory cells through the generation of reactive oxygen species

Identifiers

PMID41426519
PMCPMC12716149

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.